Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · IEX Real-Time Price · USD
0.529
+0.018 (3.44%)
At close: Mar 28, 2024, 4:00 PM
0.534
+0.005 (1.00%)
After-hours: Mar 28, 2024, 7:54 PM EDT

Salarius Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Net Income
-12.54-31.61-12.77-7.75-6.94-1.67-1.84-39.49-29.14
Depreciation & Amortization
0.010.010.020.020.130.020.020.280.05
Share-Based Compensation
0.520.80.560.320.750.0306.576.6
Other Operating Activities
-0.8413.211.99-3.3-5.525.80.270.591.75
Operating Cash Flow
-12.85-17.6-10.2-10.31-11.584.18-1.46-32.05-20.75
Capital Expenditures
000-0000-0.55-0.27
Acquisitions
0-1.5005.610000
Change in Investments
0000000-11.69-27
Other Investing Activities
-------0.03--
Investing Cash Flow
0-1.50-05.610-0.03-12.24-27.27
Dividends Paid
0000-0.130000
Share Issuance / Repurchase
6.921.9928.7714.84.132.050.010.0280.84
Debt Issued / Paid
-0.280-0.48-0.97-0.420000
Other Financing Activities
---3.87--0.620.95--
Financing Cash Flow
6.641.9928.317.693.581.440.960.0280.84
Net Cash Flow
-6.21-17.1118.17.38-2.395.61-0.53-44.2732.83
Free Cash Flow
-12.85-17.6-10.2-10.31-11.584.18-1.46-32.61-21.01
Free Cash Flow Margin
---554.29%-197.08%-334.20%214.07%-78.63%-3226.22%-
Free Cash Flow Per Share
-3.94-8.28-6.17-16.55-88.5767.84-31.73-1255.32-935.82
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).